Beijing Leadman Biochemistry Co.,Ltd.

Beijing Leadman Biochemistry Co.,Ltd.

Share · CNE100001C22 (XSHE)
Overview
AI-Powered Analysis
Fundamental Analysis
Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of Beijing Leadman Biochemistry Co.,Ltd.
No Price
Closing Price XSHE 29.04.2026: 6,76 CNY
29.04.2026 07:04
Current Prices from Beijing Leadman Biochemistry Co.,Ltd.
ExchangeTickerCurrencyLast TradePriceDaily Change
XSHE: SHENZHEN STOCK EXCHANGE
SHENZHEN STOCK EXCHANGE
300289.SZ
CNY
29.04.2026 07:04
6,76 CNY
0,25 CNY
+3,84 %
Share Float & Liquidity
Free Float 95,47 %
Shares Float 519,35 M
Shares Outstanding 544,01 M
Company Profile for Beijing Leadman Biochemistry Co.,Ltd. Share
Beijing Leadman Biochemistry Co.,Ltd. engages in the research and development, manufacture, and sale of in vitro diagnostic products in the People's Republic of China. The company offers biochemical raw materials, such as enzymes, coenzymes, antibodies, buffers, enzyme substrates, culture media, stain reagents, amino acids, and other products primarily for biotechnology, clinical diagnosis, drug development, chemical production, and other related applications. It also provides biochemistry diagnostic and companion reagents. In addition, the company offers medical instruments, such as EnigmaML, an automated molecular test platform for use in clinical laboratory and at the point-of-care, including clinics, doctor's surgeries, and pharmacies; DiaSys InnovaStar, an automatic compact POCT analyzer to deliver result quality comparable to measurements on laboratory analyzers; DiaSys Respons, a random access bench top analyzer; CI1000 automatic chemiluminescence immunoassay analyzers; and IDS-isys, an instrument to enhance performance and productivity. The company was founded in 1997 and is headquartered in Beijing, the People's Republic of China.

Company Data

Name Beijing Leadman Biochemistry Co.,Ltd.
Company Beijing Leadman Biochemistry Co.,Ltd.
Website https://www.leadmanbio.com
Primary Exchange XSHE SHENZHEN STOCK EXCHANGE
ISIN CNE100001C22
Asset Class Share
Sector Healthcare
Industry Medical - Devices
CEO Ouyang Xu
Market Capitalization 4 Mrd.
Country China
Currency CNY
Employees 0,5 T
Address No.5 Xinghai Road, 100176 Beijing
IPO Date 2012-02-16
Dividends from 'Beijing Leadman Biochemistry Co.,Ltd.'
Ex-Date Dividend per Share
17.05.2024 0,01 CNY
19.05.2022 0,02 CNY
08.06.2020 0,01 CNY
06.07.2018 0,03 CNY
15.06.2017 0,01 CNY
16.06.2016 0,06 CNY
27.05.2015 0,15 CNY
06.06.2014 0,14 CNY
13.06.2013 0,13 CNY
22.05.2012 0,10 CNY

Stock Splits

Date Split
27.10.2015 5:2

Ticker Symbols

Name Symbol
SHENZHEN STOCK EXCHANGE 300289.SZ
More Shares
Investors who hold Beijing Leadman Biochemistry Co.,Ltd. also have the following shares in their portfolio:
GROSSBRIT. 26/37
GROSSBRIT. 26/37 Bond
NSI Structured Investments Inh.-Schv.v.2020(2020/2030)
NSI Structured Investments Inh.-Schv.v.2020(2020/2030) Unbekannt